After selling its medical centers, what now for Healius (HLS). Even with its surge by 20% in share price, it is still a long way from its all-time highs. Is it now a sell or buy or hold?
A: Following the sale of its medical practices, Healius (HLS) will now be a diagnostic (pathology and imaging) business, with a small operation in private hospital day care.
The brokers like the sale, with the circa $500m being applied to reduce debt. According to FN Arena, there are 3 buy recommendations (and 3 ‘no rating’ due to restrictions).
My guess is that Healius will remain an underperformer.